Kala Pharmaceuticals, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 6 6 11 4 0 0
Przychód Δ r/r 0.0% 810.0% -90.1% -100.0% 0.0% 0.0% inf% 4.7% 76.7% -65.4% -100.0% 0.0%
Marża brutto 0.0% 0.0% 100.0% 0.0% 0.0% 0.0% 66.9% 50.1% 63.5% 34.2% -inf% 0.0%
EBIT (mln) -11 -18 -16 -33 -40 -65 -88 -96 -109 -81 -39 -41
EBIT Δ r/r 0.0% 60.3% -10.6% 104.9% 22.1% 62.3% 36.3% 9.1% 13.7% -25.7% -51.9% 4.7%
EBIT (%) -22264.0% -3920.9% -35435.6% 0.0% 0.0% 0.0% -1452.5% -1512.6% -973.6% -2090.3% 0.0% nan
Koszty finansowe (mln) 0 2 1 1 1 3 8 9 8 7 -6 -6
EBITDA (mln) -10 -17 -16 -32 -39 -63 -86 -96 -107 -82 -39 -41
EBITDA(%) -20522.0% -3836.3% -34702.2% 0.0% 0.0% 0.0% -1413.7% -1504.8% -952.3% -2097.1% 0.0% nan
Podatek (mln) 0 0 1 1 1 1 8 8 10 -45 0 0
Zysk Netto (mln) -11 -19 -17 -33 -42 -67 -102 -112 -152 -0 -42 -39
Zysk netto Δ r/r 0.0% 81.7% -13.8% 98.8% 27.3% 58.1% 52.8% 9.8% 36.0% -99.9% 18823.3% -8.7%
Zysk netto (%) -21306.0% -4255.2% -37071.1% 0.0% 0.0% 0.0% -1679.0% -1760.5% -1354.9% -5.7% 0.0% nan
EPS -22.03 -40.03 -48.26 -95.95 -305.74 -124.73 -149.06 -106.92 -116.79 -0.15 -17.35 -1.01
EPS (rozwodnione) -22.03 -40.03 -48.26 -95.95 -305.74 -124.73 -149.06 -106.92 -116.79 -0.15 -17.35 -1.01
Ilośc akcji (mln) 0 0 0 0 0 1 1 1 1 2 2 38
Ważona ilośc akcji (mln) 0 0 0 0 0 1 1 1 1 2 2 38
Waluta USD USD USD USD USD USD USD USD USD USD USD USD